New Gene Study Sheds Light on OCD and Tic Disorders
Researchers identified 36 genes linked to OCD and tic disorders in a new study reported on 2 September 2026.
Research into genes, DNA and the genome, and what they reveal about health and disease.
New Study Links 36 Genes to OCD and Tic Disorders
A new study identifies 36 genes linked to OCD and chronic tic disorders, offering fresh insight into their biological basis.
Scientists Identify Dozens of Genes Linked to OCD and Tic Disorders
Researchers identified 36 genes linked to OCD and tic disorders, offering new insight into their biological roots and future treatment paths.
New Gene Findings Offer Fresh Clues to OCD and Tic Disorders
New research identifies 36 genes linked to OCD and tic disorders, offering fresh clues for future treatments.
Ultracompact Gene Tool Could Open the Door to Smaller, More Flexible Therapies
Stanford researchers unveiled TIGRa, an ultracompact gene activation tool that may improve delivery of future therapies.
New Study Explores How Coffee’s Effects on Parkinson’s Risk May Depend on Genetics
A UK Biobank study suggests coffee’s link to Parkinson’s risk may depend on genetics and caffeine metabolism.
Researchers Report a Turning Point for Gene Editing in Severe Blood Disorders
Gene editing for severe blood disorders shows new promise after trial results suggest a reliable therapeutic strategy.
First CRISPR Phase 3 Trial Points to a Potential One-Time Treatment for Hereditary Angioedema
First phase 3 CRISPR trial for hereditary angioedema shows major attack reduction after one infusion.
CRISPR Therapy Restores Partial Vision in Early Human Trial, Offering Hope for Inherited Retinal Disease
A first-in-human CRISPR gene-editing trial for inherited retinal disease showed early improvements in vision and no serious treatment-related adverse events, say researchers.
Early Clinical Success for CRISPR Base Editing in Inherited Retinal Disease
Preliminary phase 1/2 results show safety and visual improvements with a CRISPR base-editing therapy for an inherited retinal disorder, prompting calls for larger trials.
